Dr. Stuart E. Samuels, MD, PhD

Dr. Samuels practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Samuels' NPI, 1609131523, was assigned on July 6, 2012. Dr. Samuels graduated from University of Miami, Miller School of Medicine in 2011. Dr. Samuels holds Florida license ME127765.

Dr. Samuels' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Samuels' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samuels practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Samuels' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Samuels is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Samuels' licenses on file in 2 states: Florida and Michigan.

Dmand AI lists bone cancer radiation, cancer radiation-upper GI and head & neck cancer radiation among the conditions Dr. Samuels treats.

CMS data shows 1,529 Medicare services from Dr. Samuels across 17 procedure codes in 2024, for 225 Medicare patients. Medicare paid $101,111 for them.

CMS counts 225 Medicare patients who saw Dr. Samuels in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samuels' median patient age at 72, with 35% women.

In 2024, Dr. Samuels wrote 180 Medicare Part D claims for 57 patients. 86% of them were for generic drugs. CMS names the drug for 86 of them, across 5 drugs with 11 or more claims each, at $2,678 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Samuels for performance year 2024, reported as part of a group. Dr. Samuels accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Samuels as offering telehealth.

Dmand AI links 36 papers to Dr. Samuels, published from 2013 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Radiotherapy Dosage and Brachytherapy. Dr. Samuels has published most often in Brachytherapy. Dr. Samuels' most frequent co-authors are Michael Andrew Samuels, MD, Raphael Yechieli, MD and Laura M. Freedman, MD.

CMS Open Payments shows 3 general payments to Dr. Samuels from 3 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $130.

Dmand AI lists 1 award for Dr. Samuels, most recently AOA Inductee 2011 in 2011.

Dr. Samuels graduated from University of Miami, Miller School of Medicine in 2011. Dr. Samuels is a member of AOA.

Dr. Samuels is in network with 12 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.